Endometrial cancer

GPTKB entity

Statements (56)
Predicate Object
gptkbp:instance_of gptkb:healthcare_organization
gptkbp:bfsLayer 4
gptkbp:bfsParent gptkb:Dixie_Carter
gptkbp:affects endometrium
gptkbp:age postmenopausal women
women over 60
gptkbp:current_use gptkb:Lynch_syndrome
polycystic ovary syndrome
gptkbp:end_of_life approximately 17% for distant cases
approximately 81% for localized cases
gptkbp:events may include imaging tests
important for monitoring recurrence
regular check-ups recommended
gptkbp:genetic_diversity gptkb:physicist
gptkb:PTEN_mutation
p53 mutation
https://www.w3.org/2000/01/rdf-schema#label Endometrial cancer
gptkbp:is_protected_by maintaining a healthy weight
managing diabetes
regular gynecological exams
gptkbp:number_of_stages Stage I
Stage II
Stage III
Stage IV
gptkbp:occurs_in most common gynecological cancer in developed countries
rising incidence in recent years
gptkbp:personal_life alcohol consumption may influence risk
diet high in fruits and vegetables may reduce risk
physical activity may reduce risk
smoking may increase risk
gptkbp:provides_information_on ASCO guidelines available
NCCN guidelines available
gptkbp:research_focus gptkb:vaccine
biomarkers for early detection
genetic profiling for personalized treatment
gptkbp:risk_factor gptkb:Company
hormone replacement therapy
obesity
age over 50
gptkbp:scholarships counseling services available
educational resources available
support groups available
gptkbp:screenings no standard screening test
transvaginal ultrasound for high-risk women
gptkbp:social_responsibility ultrasound
biopsy
depends on stage
early detection improves survival
gptkbp:symptoms pelvic pain
abnormal vaginal bleeding
gptkbp:treatment gptkb:hospital
radiation therapy
chemotherapy
hormonal therapy
clinical trials available
targeted therapy under investigation